bpc-157 fda warning compounding issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA's Overreach on Compounded Peptides

Verdict for antioxidant/senescence research: GHK-Cu is the stronger candidate for antioxidant and cellular senescence research, given its documented broad antioxidant transcriptome remodelling and direct SASP modulation

- AHK-Cu is a copper-binding research peptide studied in models involving hair follicle biology, skin-cell signaling, extracellular matrix pathways, collagen-associated research, angiogenesis models, tissue remodeling, and copper peptide signaling

Chronic liver disease or acute liver failure can lower factor production, impair vitamin K processing, and produce coagulopathy, leading to easy bruising and bleeding

The answer: largely through compounding pharmacies and gray-market suppliers

BPC-157 is a synthetic 15-amino-acid peptide based on a sequence found in a protein in gastric juice